Cerebral (Fatal) Malaria Global Clinical Trials Review, H2, 2014
Summary
GlobalData's clinical trial report, “Cerebral (Fatal) Malaria Global Clinical Trials Review, H2, 2014" provides data on the Cerebral (Fatal) Malaria clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cerebral (Fatal) Malaria. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cerebral (Fatal) Malaria. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Cerebral (Fatal) Malaria 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Cerebral (Fatal) Malaria to Infectious Disease Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Cerebral (Fatal) Malaria to Infectious Disease Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Unaccomplished Trials of Cerebral (Fatal) Malaria 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Cerebral (Fatal) Malaria Therapeutics Clinical Trials 27
Prominent Drugs 28
Clinical Trial Profiles 29
Clinical Trial Overview of Top Companies 29
Bharat Biotech International Limited 29
Clinical Trial Overview of Bharat Biotech International Limited 29
Bayer AG 30
Clinical Trial Overview of Bayer AG 30
Clinical Trial Overview of Top Institutes / Government 31
University of Rochester 31
Clinical Trial Overview of University of Rochester 31
Makerere University 32
Clinical Trial Overview of Makerere University 32
Office of the Surgeon General of the Army, Department of Defense 33
Clinical Trial Overview of Office of the Surgeon General of the Army, Department of Defense 33
Griffith University 34
Clinical Trial Overview of Griffith University 34
The Universite Claude Bernard Lyon 1 35
Clinical Trial Overview of The Universite Claude Bernard Lyon 1 35
Menzies School of Health Research 36
Clinical Trial Overview of Menzies School of Health Research 36
The University of Utah 37
Clinical Trial Overview of The University of Utah 37
University of Oxford 38
Clinical Trial Overview of University of Oxford 38
Five Key Clinical Profiles 39
Appendix 58
Abbreviations 58
Definitions 58
Research Methodology 59
Secondary Research 59
About GlobalData 60
Contact Us 60
Disclaimer 60
Source 60
List Of Tables
List of Tables
Cerebral (Fatal) Malaria Therapeutics, Global, Clinical Trials by Region, 2014* 6
Cerebral (Fatal) Malaria Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Cerebral (Fatal) Malaria Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Cerebral (Fatal) Malaria Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Cerebral (Fatal) Malaria Therapeutics Clinical Trials, Europe, Top Countries, 2014* 10
Cerebral (Fatal) Malaria Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Cerebral (Fatal) Malaria Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12
Proportion of Cerebral (Fatal) Malaria to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 13
Cerebral (Fatal) Malaria Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Cerebral (Fatal) Malaria Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Cerebral (Fatal) Malaria to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 16
Cerebral (Fatal) Malaria Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Cerebral (Fatal) Malaria Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18
Cerebral (Fatal) Malaria Therapeutics, Global, Clinical Trials by Phase, 2014* 19
Cerebral (Fatal) Malaria Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 20
Cerebral (Fatal) Malaria Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Cerebral (Fatal) Malaria Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Cerebral (Fatal) Malaria Therapeutics, Global, Suspended Clinical Trials, 2014* 23
Cerebral (Fatal) Malaria Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Cerebral (Fatal) Malaria Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 25
Cerebral (Fatal) Malaria Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26
Cerebral (Fatal) Malaria Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 27
Cerebral (Fatal) Malaria Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 28
Cerebral (Fatal) Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Bharat Biotech International Limited, 2014* 29
Cerebral (Fatal) Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 30
Cerebral (Fatal) Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Rochester, 2014* 31
Cerebral (Fatal) Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Makerere University, 2014* 32
Cerebral (Fatal) Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Office of the Surgeon General of the Army, Department of Defense, 2014* 33
Cerebral (Fatal) Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Griffith University, 2014* 34
Cerebral (Fatal) Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by The Universite Claude Bernard Lyon 1, 2014* 35
Cerebral (Fatal) Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Menzies School of Health Research, 2014* 36
Cerebral (Fatal) Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Utah, 2014* 37
Cerebral (Fatal) Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2014* 38
List Of Figures
List of Figures
Cerebral (Fatal) Malaria Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Cerebral (Fatal) Malaria Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Cerebral (Fatal) Malaria Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Cerebral (Fatal) Malaria Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Cerebral (Fatal) Malaria Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 12
Proportion of Cerebral (Fatal) Malaria to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 13
Cerebral (Fatal) Malaria Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Cerebral (Fatal) Malaria Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Cerebral (Fatal) Malaria to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 16
Cerebral (Fatal) Malaria Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Cerebral (Fatal) Malaria Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18
Cerebral (Fatal) Malaria Therapeutics, Global, Clinical Trials by Phase (%), 2014* 19
Cerebral (Fatal) Malaria Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 20
Cerebral (Fatal) Malaria Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Cerebral (Fatal) Malaria Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Cerebral (Fatal) Malaria Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Cerebral (Fatal) Malaria Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 25
Cerebral (Fatal) Malaria Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26
Cerebral (Fatal) Malaria Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 27
Cerebral (Fatal) Malaria Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 28
GlobalData Methodology 59
